Consistent with this, apoptosis analysis data also show that overexpression of NF1 can abolish miR‐641‐induced protection effects of NSCLC cells to erlotinib treatment (Fig. 5D). This evidence concerns the gene NF1 and non-small cell lung carcinoma.